216 related articles for article (PubMed ID: 9830464)
1. Therapy and prophylaxis of acute and late radiation-induced sequelae of the esophagus.
Zimmermann FB; Geinitz H; Feldmann HJ
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():78-81. PubMed ID: 9830464
[TBL] [Abstract][Full Text] [Related]
2. Radiation proctitis. Clinical and pathological manifestations, therapy and prophylaxis of acute and late injurious effects of radiation on the rectal mucosa.
Zimmermann FB; Feldmann HJ
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():85-9. PubMed ID: 9830466
[TBL] [Abstract][Full Text] [Related]
3. Protection of normal tissues from the cytotoxic effects of radiation therapy: focus on amifostine.
Mehta MP
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):14-6. PubMed ID: 9794996
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
Movsas B; Scott C; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Smith C; Axelrod R; Sarna L; Wasserman T; Byhardt R
J Clin Oncol; 2005 Apr; 23(10):2145-54. PubMed ID: 15800308
[TBL] [Abstract][Full Text] [Related]
5. Injurious effects of radiation on the esophagus.
Chowhan NM
Am J Gastroenterol; 1990 Feb; 85(2):115-20. PubMed ID: 2405641
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of acute radiation morbidity.
Zimmermann JS; Kimmig B
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():62-5. PubMed ID: 9830460
[TBL] [Abstract][Full Text] [Related]
7. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
Mehta V
Semin Oncol; 2004 Dec; 31(6 Suppl 18):42-6. PubMed ID: 15726522
[TBL] [Abstract][Full Text] [Related]
8. Mucosal bridges of the upper esophagus after radiotherapy for Hodgkin's disease.
Papazian A; Capron JP; Ducroix JP; Dupas JL; Quenum C; Besson P
Gastroenterology; 1983 May; 84(5 Pt 1):1028-31. PubMed ID: 6832554
[TBL] [Abstract][Full Text] [Related]
9. [Acute gastrointestinal side effects of radiotherapy. What is certain in the treatment?].
Paulsen F; Hoffmann W; Kortmann RD; Porschen R; Bamberg M
Strahlenther Onkol; 1996 Feb; 172(2):53-63. PubMed ID: 8669046
[TBL] [Abstract][Full Text] [Related]
10. [Eosinophilic esophagitis: new standards in diagnosis and therapy of chronic retrosternal pain].
Engel MA; Raithel M; Hahn EG; Konturek PC
Dtsch Med Wochenschr; 2008 May; 133(18):966-71. PubMed ID: 18431707
[TBL] [Abstract][Full Text] [Related]
11. Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents.
Vujaskovic Z; Thrasher BA; Jackson IL; Brizel MB; Brizel DM
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):534-40. PubMed ID: 17869666
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium meclofenamate on radiation-induced esophagitis and cystitis.
Ambrus JL; Ambrus CM; Lillie DB; Johnson RJ; Gastpar H; Kishel S
J Med; 1984; 15(2):81-92. PubMed ID: 6595342
[TBL] [Abstract][Full Text] [Related]
13. Radiation esophagitis.
Murro D; Jakate S
Arch Pathol Lab Med; 2015 Jun; 139(6):827-30. PubMed ID: 26030254
[TBL] [Abstract][Full Text] [Related]
14. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
15. [Esophageal toxicity of radiation therapy: clinical risk factors and management].
Challand T; Thureau S; Dubray B; Giraud P
Cancer Radiother; 2012 Sep; 16(5-6):364-71. PubMed ID: 22925486
[TBL] [Abstract][Full Text] [Related]
16. Esophageal mucosal bridge in a young man with radiation esophagitis.
Cunningham S; Singla M; Itzkowitz S
Gastrointest Endosc; 2015 Dec; 82(6):1121. PubMed ID: 26183826
[No Abstract] [Full Text] [Related]
17. Radiation-induced toxicities: the role of radioprotectants.
Curran WJ
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
19. Treatment-related esophagitis.
Werner-Wasik M
Semin Oncol; 2005 Apr; 32(2 Suppl 3):S60-6. PubMed ID: 16015537
[TBL] [Abstract][Full Text] [Related]
20. Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study.
Algara M; Rodríguez N; Viñals P; Lacruz M; Foro P; Reig A; Quera J; Lozano J; Fernández-Velilla E; Membrive I; Dengra J; Sanz X
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):342-9. PubMed ID: 17531398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
